New Technology Revolutionizes DNA Testing of Sexual Assault Samples

New technology revolutionizes DNA testing of sexual assault samples

InnoGenomics SpermX™ delivers reliable results to solve sexual assault crimes

NEW ORLEANS (March 28, 2023) – Addressing a long-term shortcoming in DNA evidence for rape and sexual assault cases, New Orleans-based InnoGenomics has developed a nanotech method, SpermX™, that drastically increases usable results to solve more crimes. 

The novel nanotechnology-derived polymer outperforms conventional methods, capturing male DNA from as few as 25 sperm cells while minimizing DNA contribution from the victim. The method can also be automated for labs with larger caseloads. 

“Nearly 60% of sexual assault kits tested with traditional methods do not recover enough male DNA to obtain a usable DNA profile from the offender,” says Dr. Sudhir Sinha, InnoGenomics CEO, “SpermX™ changes that.” 

“Our nanotech method is up to six times more efficient at extracting male DNA profiles, especially from low-level sperm samples. We can significantly improve the probability of solving sexual assault crimes by using this method.” 

Conventional forensic laboratory methods for processing sexual assault samples typically only recover 5-30% of the sperm in the sample, resulting in many kits testing positive for male DNA but not providing enough genetic information for a criminal investigation. Traditional methods produce usable DNA profiles only 10% of the time from samples with lower sperm amounts, such as oral swabs.

A recent interlaboratory study performed by the University of Central Florida (UCF), Center for Forensic Science Research and Education (CFSRE), and InnoGenomics (IGT), demonstrated the benefits of the SpermX™ method. Participating laboratories achieved informative DNA profiles from over 10% of low-level sperm samples and recovered sperm from samples containing as few as 25 sperm cells. In contrast, traditional methods yielded informative profiles from only 16% of these low-level samples. The study results were presented at the 2023 American Academy of Forensic Sciences Annual Conference.

“This data demonstrates that SpermX outperforms older methods when dealing with very low sperm amounts,” says Dr. Jack Ballantyne, UCF professor of Chemistry and Associate Director for Research at the National Center for Forensic Science. “For SpermX, the male DNA was easily detectible. We’re really quite impressed with the difference between the methods based on this data.” 

Over the last 20 years, DNA testing of rape kits, along with the establishment of national DNA databases, have become a powerful tool for solving sexual assault cases. The ability to separate sperm cells from other cells to obtain a DNA profile from the perpetrator has been a key factor in solving these cases SpermX™’s ability to derive male DNA profiles from as few as 25 sperm cells has the potential to revolutionize the handling of sexual assault and rape cases, providing almost routine solutions with its advanced testing capabilities.


InnoGenomics Technologies (IGT): Dedicated to the development of innovative genetic testing solutions that solve crimes and save lives, IGT is a client of the New Orleans BioInnovation Center (NOBIC). With support from National Science Foundation SBIR grants, IGT developed novel patented technology scalable across applications including forensic and missing-person identification, relationship and ancestral ethno-geographic establishment and molecular diagnostics. The IGT team has in-depth expertise in molecular biology, forensic genetics and molecular diagnostics. Its management team has over 85 combined years of experience in successful biotechnology commercialization. IGT focuses on harnessing the power of genomics to transform health care and forensic investigations. IGT is a BioFund Portfolio Company.


Local Biotech Company is Improving Clinical Care for Animals

Local Biotech Company is Improving Clinical Care for Animals

PetVet Dx celebrated recent expansion and future plans at a community event Friday

NEW ORLEANS (March 31, 2023) Local biotech company PetVet Dx hosted a community event last Friday to celebrate their recent expansion in the New Orleans BioInnovation Center (NOBIC.) The program capped off with a donation to both the New Orleans Police Department Canine Unit and Audubon Zoo.

PetVet Dx is a therapeutic management company specializing in Infectious Disease and Cancer molecular diagnostic testing to improve clinical care in all species of animals. Its revolutionary technology provides an effective and efficient testing product for veterinarians, farmers, and pet owners. 

“As a company, we felt it was important to thank the community we are a part of,” said David Kutrucz, President of PetVetDX. “Support the NOPD Canine Unit and Audubon Zoo just made sense. Not only are we proud to make a monetary donation, we also donated our diagnostic services.”

PetVet Dx offers the most comprehensive infectious disease tests and identification of antibiotic resistance genes on the market.  PetVet Dx is the only laboratory in the nation utilizing and offering the most advanced, CDC-recommended technology to produce the most comprehensive reporting within 24 hours with an unequaled accuracy rate of 99.8%.

In addition, PetVet Dx’s testing solution provides you with pharmacological antibiotic medication reporting to help veterinarians, pet owners, and farmers better understand identified infections and their treatment.

For more information, please visit here.


PetVet Dx: PetVet Dx is a therapeutic management company specializing in targeted PCR molecular diagnostics to improve clinical care in all species of animals. Our revolutionary molecular technology provides a firm foundation for diagnostics in animal health services for veterinarians, farmers, and pet owners. PetVet Dx believes that the only diagnostic test that should be performed is one that will improve an animal’s overall outcome.